– USA, MN – Otter Tail Corporation (NASDAQ: OTTR) today announced the appointment of Dr. Michael LeBeau to its Board of Directors, effective January 1, 2022.
Dr. LeBeau has extensive leadership and health and public policy expertise within the health services industry. He currently serves as System VP and Chief Administrative Officer for the health services division of Sanford Health.
“Michael will bring great perspective. His familiarity with North Dakota and depth of professional experience will offer tremendous insights to our board,” said Board Chairman, Nathan Partain.
About Dr. LeBeau
Dr. LeBeau is an active community leader, serving as a board member for the University of North Dakota Alumni Association and Foundation, the Bismarck State College Foundation, North Dakota Hospital Association, Missouri Family Valley YMCA of Bismarck, and University of North Dakota School of Medicine & Health Sciences Advisory Board. He graduated from the University of North Dakota School of Medicine & Health Sciences, fulfilled his residency in internal medicine at Gunderson Lutheran Medical Foundation, completed a nephrology fellowship at the University of Iowa, and is board certified by the American Board of Internal Medicine.
About Otter Tail Corporation
Otter Tail Corporation has interests in diversified operations that include an electric utility and manufacturing businesses. Otter Tail Corporation stock trades on the Nasdaq Global Select Market under the symbol OTTR. The latest investor and corporate information are available at www.ottertail.com. Corporate offices are in Fergus Falls, Minnesota, and Fargo, North Dakota.
For more information : https://ottertail.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.